IL155259A0 - New derivatives of cyano-aryl) or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication - Google Patents
New derivatives of cyano-aryl) or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medicationInfo
- Publication number
- IL155259A0 IL155259A0 IL15525901A IL15525901A IL155259A0 IL 155259 A0 IL155259 A0 IL 155259A0 IL 15525901 A IL15525901 A IL 15525901A IL 15525901 A IL15525901 A IL 15525901A IL 155259 A0 IL155259 A0 IL 155259A0
- Authority
- IL
- Israel
- Prior art keywords
- cyanoheteroaryl
- pyrimidines
- piperazinyl
- medication
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200002532A ES2167276B1 (es) | 2000-10-20 | 2000-10-20 | Nuevos derivados de cianoaril (o cianoheteroaril)-carbonil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
| PCT/ES2001/000378 WO2002032880A1 (es) | 2000-10-20 | 2001-10-10 | Nuevos derivados de cianoaril (o cianoheteroaril)-carbonil-piperazinil-pirimidinas, su preparación y su aplicación como medicamentos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL155259A0 true IL155259A0 (en) | 2003-11-23 |
Family
ID=8495344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15525901A IL155259A0 (en) | 2000-10-20 | 2001-10-10 | New derivatives of cyano-aryl) or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7300937B2 (xx) |
| EP (1) | EP1327630B1 (xx) |
| JP (1) | JP2004511550A (xx) |
| KR (1) | KR20030037687A (xx) |
| CN (1) | CN1221536C (xx) |
| AR (1) | AR030885A1 (xx) |
| AT (1) | ATE380795T1 (xx) |
| AU (2) | AU9387701A (xx) |
| BR (1) | BR0114999A (xx) |
| CA (1) | CA2426097A1 (xx) |
| CZ (1) | CZ20031116A3 (xx) |
| DE (1) | DE60131873T2 (xx) |
| ES (2) | ES2167276B1 (xx) |
| HK (1) | HK1060358A1 (xx) |
| HU (1) | HUP0302901A3 (xx) |
| IL (1) | IL155259A0 (xx) |
| MX (1) | MXPA03003348A (xx) |
| NO (1) | NO20031771L (xx) |
| NZ (1) | NZ525246A (xx) |
| PL (1) | PL361033A1 (xx) |
| PT (1) | PT1327630E (xx) |
| RU (1) | RU2259358C2 (xx) |
| TW (1) | TWI220144B (xx) |
| WO (1) | WO2002032880A1 (xx) |
| ZA (1) | ZA200302452B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL212089B1 (pl) * | 2002-03-13 | 2012-08-31 | Janssen Pharmaceutica Nv | Związki heterocykliczne jako inhibitory deacetylazy histonowej, kompozycja farmaceutyczna je zawierająca, ich zastosowanie, sposób wytwarzania, sposób wykrywania lub identyfikacji HDAC oraz kompozycja |
| CN103360343B (zh) * | 2012-03-30 | 2017-04-19 | 凯惠药业(上海)有限公司 | 一种哌嗪酰胺类化合物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2535718A1 (fr) * | 1982-11-09 | 1984-05-11 | Sanofi Sa | (piperazinyl-1)-2 pyrimidines, leurs sels, procede pour leur preparation et compositions pharmaceutiques en contenant |
| US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
| US4668687A (en) * | 1984-07-23 | 1987-05-26 | Bristol-Myers Company | Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones |
| FR2642759B1 (fr) | 1989-02-09 | 1991-05-17 | Laboratorios Esteve Sa | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante |
| FR2654621B1 (fr) * | 1989-11-22 | 1994-09-23 | Esteve Labor Dr | Inhibition du syndrome d'abstinence. |
| FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
| JPH04202185A (ja) * | 1990-11-30 | 1992-07-22 | Terumo Corp | ピペラジン誘導体及びこれを含有する医薬製剤 |
| ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
-
2000
- 2000-10-20 ES ES200002532A patent/ES2167276B1/es not_active Expired - Fee Related
-
2001
- 2001-10-10 EP EP01974344A patent/EP1327630B1/en not_active Expired - Lifetime
- 2001-10-10 MX MXPA03003348A patent/MXPA03003348A/es active IP Right Grant
- 2001-10-10 CN CNB018176291A patent/CN1221536C/zh not_active Expired - Fee Related
- 2001-10-10 AT AT01974344T patent/ATE380795T1/de not_active IP Right Cessation
- 2001-10-10 NZ NZ525246A patent/NZ525246A/en unknown
- 2001-10-10 CZ CZ20031116A patent/CZ20031116A3/cs unknown
- 2001-10-10 US US10/312,195 patent/US7300937B2/en not_active Expired - Fee Related
- 2001-10-10 JP JP2002536263A patent/JP2004511550A/ja active Pending
- 2001-10-10 KR KR10-2003-7005303A patent/KR20030037687A/ko active IP Right Grant
- 2001-10-10 BR BR0114999-7A patent/BR0114999A/pt not_active IP Right Cessation
- 2001-10-10 PL PL01361033A patent/PL361033A1/xx not_active Application Discontinuation
- 2001-10-10 CA CA002426097A patent/CA2426097A1/en not_active Abandoned
- 2001-10-10 HU HU0302901A patent/HUP0302901A3/hu unknown
- 2001-10-10 AU AU9387701A patent/AU9387701A/xx active Pending
- 2001-10-10 RU RU2003114437/04A patent/RU2259358C2/ru not_active IP Right Cessation
- 2001-10-10 PT PT01974344T patent/PT1327630E/pt unknown
- 2001-10-10 ES ES01974344T patent/ES2296806T3/es not_active Expired - Lifetime
- 2001-10-10 AU AU2001293877A patent/AU2001293877B2/en not_active Ceased
- 2001-10-10 DE DE60131873T patent/DE60131873T2/de not_active Expired - Lifetime
- 2001-10-10 WO PCT/ES2001/000378 patent/WO2002032880A1/es active IP Right Grant
- 2001-10-10 IL IL15525901A patent/IL155259A0/xx unknown
- 2001-10-12 AR ARP010104819A patent/AR030885A1/es unknown
- 2001-10-17 TW TW090125627A patent/TWI220144B/zh not_active IP Right Cessation
-
2003
- 2003-03-28 ZA ZA200302452A patent/ZA200302452B/en unknown
- 2003-04-16 NO NO20031771A patent/NO20031771L/no not_active Application Discontinuation
-
2004
- 2004-05-14 HK HK04103417A patent/HK1060358A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20031771L (no) | 2003-06-06 |
| AU9387701A (en) | 2002-04-29 |
| ES2167276B1 (es) | 2003-04-01 |
| HUP0302901A3 (en) | 2004-04-28 |
| RU2259358C2 (ru) | 2005-08-27 |
| EP1327630B1 (en) | 2007-12-12 |
| BR0114999A (pt) | 2004-02-03 |
| ATE380795T1 (de) | 2007-12-15 |
| DE60131873T2 (de) | 2008-12-04 |
| CA2426097A1 (en) | 2003-04-16 |
| NZ525246A (en) | 2004-11-26 |
| AR030885A1 (es) | 2003-09-03 |
| ZA200302452B (en) | 2004-03-29 |
| PL361033A1 (en) | 2004-09-20 |
| ES2296806T3 (es) | 2008-05-01 |
| CN1221536C (zh) | 2005-10-05 |
| HK1060358A1 (en) | 2004-08-06 |
| US7300937B2 (en) | 2007-11-27 |
| HUP0302901A2 (hu) | 2004-03-01 |
| NO20031771D0 (no) | 2003-04-16 |
| TWI220144B (en) | 2004-08-11 |
| EP1327630A1 (en) | 2003-07-16 |
| US20040048872A1 (en) | 2004-03-11 |
| KR20030037687A (ko) | 2003-05-14 |
| JP2004511550A (ja) | 2004-04-15 |
| WO2002032880A1 (es) | 2002-04-25 |
| CZ20031116A3 (cs) | 2003-10-15 |
| MXPA03003348A (es) | 2003-06-19 |
| CN1469866A (zh) | 2004-01-21 |
| ES2167276A1 (es) | 2002-05-01 |
| PT1327630E (pt) | 2008-03-05 |
| DE60131873D1 (de) | 2008-01-24 |
| AU2001293877B2 (en) | 2007-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1070053A1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| HUP0303103A3 (en) | Fused pyrrolocarbazoles, pharmaceutical compositions containing them and use of the compounds | |
| AU3958100A (en) | New compounds, their preparation and use | |
| AU3958200A (en) | New compounds, their preparation and use | |
| HUP0402566A3 (en) | C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them | |
| HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
| AU3957900A (en) | New compounds, their preparation and use | |
| AU2268301A (en) | Novel urea compounds, compositions and methods of use and preparation | |
| AU2001248279A1 (en) | New compounds, their preparation and use | |
| HK1032958A1 (en) | Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments. | |
| HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
| HUP0102678A3 (en) | Phenyl-methoxyimino-acetic acid derivatives as pesticides, intermediates, preparation and use thereof | |
| AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
| IL176524A0 (en) | Ascorbic acid compounds, methods of synthesis and application use thereof | |
| HUP0401644A3 (en) | Aminobenzoephenones, pharmaceutical compositions containing them and use thereof | |
| HUP0401713A3 (en) | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | |
| HUP0303804A3 (en) | Ligands of the avss6 integrin, process for their preparation, their use and pharmaceutical compositions containing them | |
| AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
| AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AU7402201A (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| IL158587A0 (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof | |
| IL155259A0 (en) | New derivatives of cyano-aryl) or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication | |
| AU2001293877A1 (en) | New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication | |
| AR026890A1 (es) | Composiciones de tenocitos, preparaciones y utilizaciones |